Resting Metabolic Rate (RMR) Measures how many calories your body burns at rest, helping personalise your nutrition plan
[1] Fig 1: Obesity market is projected to grow exponentially in the coming years What is now a highly consolidated market dominated by Lilly and Novo Nordisk is poised to become increasingly competitive and complex
Rather than competing for identical cell receptors, these two compounds complement each other during tissue remodeling assessments
Over time, the body adapts to: Lower calorie intake Reduced hunger signals Altered satiety feedback When medication is stopped suddenly, these adaptations dont disappear gradually they often snap back quickly , creating a biological mismatch between appetite and metabolic capacity
Semaglutide, a GLP-1 receptor agonist originally designed for type 2 diabetes, has demonstrated significant effects on lipid metabolism beyond weight reduction
Each of these substances belongs to a family called GLP-1 agonists